The Abigail Wexner Research Institute
Helping Kids Everywhere
A Look Inside the Abigail Wexner Research Institute at Nationwide Children's Hospital
The Research Institute at Nationwide Children’s has been renamed in honor of Abigail Wexner, whose ongoing, passionate advocacy has ushered in a period of unprecedented transformation at the hospital. Mrs. Wexner began serving on Nationwide Children’s board in 1993 and acted as board chair for seven years from 2005 to 2012. During her tenure as chair, Mrs. Wexner led the hospital through the largest expansion in its 127-year history, including completion of a 12-story hospital building and a third research building, with more than $1.2 billion in regional economic impact.
Research at Nationwide Children's
The Abigail Wexner Research Institute at Nationwide Children's Hospital is seeking answers on behalf of children in Columbus and around the world. Our thirteen multidisciplinary Centers of Emphasis span the spectrum of research important to pediatric health. Our common goal is discovery and innovation that improves the health and quality of life for children and their families.
The FDA issued an approval for the gene therapy for SMA developed at Nationwide Children's, laying the groundwork for it to change the lives of children all over the country.